<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01087372</url>
  </required_header>
  <id_info>
    <org_study_id>Incretins2010</org_study_id>
    <nct_id>NCT01087372</nct_id>
  </id_info>
  <brief_title>Stress Hyperglycemia. Potential Role of Incretin Analogs</brief_title>
  <official_title>Stress Hyperglycemia in Critically Ill Patients. Potential Role of Incretin Analogs. A Preliminary Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Son Dureta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundaci√≥ Mateu Orfila</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Son Dureta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study to examine the levels of glucoregulatory hormones,
      with special focus on incretins levels, in critically ill patients with stress hyperglycemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incretins plasmatic levels</measure>
    <time_frame>28 days</time_frame>
    <description>28 days and ICU mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>glucagon</measure>
    <time_frame>28 days</time_frame>
    <description>28 days and ICU mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin</measure>
    <time_frame>28 days</time_frame>
    <description>28 days and ICU mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cortisol</measure>
    <time_frame>28 days</time_frame>
    <description>28 days and ICU mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA index</measure>
    <time_frame>28 days</time_frame>
    <description>28 days and ICU mortality</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hyperglycemia</condition>
  <condition>Critical Illness</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum samples to analyze glucorregulatory hormones.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Medical-surgical ICU patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Emergent ICU admission

          -  Written informed consent from patient or relative.

        Exclusion Criteria:

          -  Previously known type I or type II diabetes.

          -  Patients who received insulin or oral antidiabetic agents before ICU admission.

          -  Malignancies.

          -  Scheduled surgery

          -  Patients receiving enteral or parenteral nutrition.

          -  Inability to obtain informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan A Llompart-Pou, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Son Dureta. Intensive Care Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitari Son Dureta. Intensive Care Unit</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Illes Balears</state>
        <zip>07014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2010</study_first_submitted>
  <study_first_submitted_qc>March 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2010</study_first_posted>
  <last_update_submitted>June 7, 2010</last_update_submitted>
  <last_update_submitted_qc>June 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Juan A Llompart-Pou</name_title>
    <organization>Hospital Universitari Son Dureta</organization>
  </responsible_party>
  <keyword>Stress hyperglycemia</keyword>
  <keyword>Incretins</keyword>
  <keyword>GLP-1</keyword>
  <keyword>GIP</keyword>
  <keyword>glucoregulatory hormones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Incretins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

